Top compounds associated with response to DTD2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA isonicotinohydroxamic acid CTRPv2 pan-cancer AAC -0.035 0.5
mRNA Crizotinib gCSI pan-cancer AAC 0.042 0.5
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC 0.04 0.5
mRNA CIL55A CTRPv2 pan-cancer AAC -0.038 0.5
mRNA barasertib CTRPv2 pan-cancer AAC 0.023 0.5
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.027 0.5
mRNA GDC-0941 CTRPv2 pan-cancer AAC 0.026 0.5
mRNA VER-155008 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA etomoxir CTRPv2 pan-cancer AAC 0.027 0.5
Download CSV